At the end of November 2025, the authorized share capital of Dawnrays Pharmaceutical (Holdings) Limited (Stock Code: 02348) remained at HKD1,000,000,000, comprising 20,000,000,000 ordinary shares with a par value of HKD0.05 each. No increase or decrease in authorized share capital was reported during the month.

The total number of issued ordinary shares stayed at 1,503,357,000, with no treasury shares recorded. Under the 2013 Share Option Scheme, 8,828,000 share options remained outstanding at the end of November, and the potential shares to be issued pursuant to this scheme stood at 7,556,000. Under the 2023 Share Option Scheme, 16,000,000 share options remained outstanding, with 3,200,000 potential shares to be issued accordingly. No new shares were issued, and total funds raised from exercising options stood at HKD0, indicating no change in shareholder structure for the month.